toxylact: a07bc other intestinal adsorbents

The first professional lActological database in the word

Other intestinal adsorbents (ATC A07BC) are locally acting antidiarrheal agents such as pectin, kaolin, crospovidone, attapulgite and diosmectite, which act within the gut lumen with minimal systemic absorption and are therefore expected to have low direct risk in breastfeeding, although product‑specific precautions exist.atcddd.fhi+2

ATC A07BC overview

The ATC subgroup A07BC “Other intestinal adsorbents” includes all intestinal adsorbents that are not classified as charcoal (A07BA) or bismuth preparations (A07BB). Current 5th‑level entries comprise pectin (A07BC01), kaolin (A07BC02), crospovidone (A07BC03), attapulgite (A07BC04), diosmectite (A07BC05), as well as combinations and attapulgite combinations.atcddd.fhi+3

Mechanism of action

These agents act mainly by physical adsorption of water, toxins, bile salts, and other molecules, and by coating or protecting the intestinal mucosa, thereby reducing stool liquidity and irritation. Clay‑based adsorbents such as attapulgite and diosmectite also reinforce the mucus barrier through interactions with mucosal glycoproteins and have high surface binding capacity for various luminal substances.pmc.ncbi.nlm.nih+4

Main therapeutic indications

Drugs in A07BC are used as symptomatic treatment of acute diarrhea and, in some cases, chronic functional bowel disorders in adults, often as adjuncts to oral rehydration. Diosmectite, for example, is indicated for acute and chronic diarrhea and functional bowel pain, and has been shown to reduce the duration and frequency of bowel movements in mild‑to‑moderate acute pediatric diarrhea.pmc.ncbi.nlm.nih+2

Pharmacokinetics relevant to lactation

Pectin, kaolin, attapulgite, diosmectite and related clays are essentially not absorbed from the intact gastrointestinal tract and are excreted unchanged in the feces. Crospovidone is an insoluble cross‑linked polymer used as an enterosorbent; it likewise remains in the gut lumen with negligible systemic bioavailability, supporting minimal transfer into human milk.ebi+3

Maternal safety and adverse effects

At usual doses, A07BC adsorbents are generally well tolerated; the main adverse effect is constipation, while nausea or vomiting occurs less frequently. Hypersensitivity reactions (rash, urticaria, angioedema) are rare but have been described, and clay‑based products are contraindicated in patients with known hypersensitivity or significant intestinal obstruction.pmc.ncbi.nlm.nih+2

Specific considerations for diosmectite

Diosmectite (dioctahedral smectite) is a double silicate of aluminium and magnesium with strong mucosal‑coating and adsorptive properties, used in adults and children for acute and chronic diarrhea and functional colopathy. Regulatory agencies have reviewed trace lead content and, as a precaution and because of limited data, some authorities now recommend against its use in pregnant and breastfeeding women despite a generally favorable safety profile in adults and children when used short‑term.pmc.ncbi.nlm.nih+4

Lactation safety profile of A07BC group

Given their lack of systemic absorption, most A07BC adsorbents (pectin, kaolin, attapulgite, crospovidone) are expected to result in negligible exposure of the breastfed infant via milk and are considered low‑risk from a toxicological standpoint. For diosmectite, the theoretical risk from trace heavy metals is extremely low, but precautionary labeling to avoid its use in breastfeeding reflects regulatory conservatism in the absence of dedicated lactation studies rather than evidence of harm.atcddd.fhi+5

Potential effects on the breastfed infant

Direct drug‑related effects in the infant from maternal use of non‑absorbed adsorbents are unlikely, as these substances do not reach the maternal circulation in significant amounts and therefore do not reach milk in clinically relevant concentrations. Any clinical concerns for the infant are more likely to relate to transmission of the underlying infectious diarrhea or to maternal dehydration, rather than to the adsorbent itself.atcddd.fhi+3

Practical recommendations in breastfeeding

For breastfeeding women with mild, self‑limited diarrhea, first‑line management remains oral rehydration and supportive care; if an adsorbent is desired, non‑absorbed agents from A07BC (such as pectin‑ or kaolin‑based products) can be considered, with attention to local licensing and product composition. Where diosmectite is available, clinicians should be aware of national regulatory advice that may recommend avoiding its use in breastfeeding due to limited data, and may instead prefer alternatives with clearer lactation guidance.atcddd.fhi+5

Risk–benefit assessment

Overall, the A07BC “other intestinal adsorbents” have a favorable risk–benefit balance in breastfeeding when used short‑term and at recommended doses, owing to their local action and negligible systemic absorption. Choice within the class should prioritize agents without specific pregnancy/lactation restrictions in local regulatory guidance, while also addressing the cause and severity of diarrhea and ensuring adequate maternal hydration and infant monitoring.atcddd.fhi+4

Recent ARTICLES

July 24

Abdominal Compartment Syndrome

PWhile the formal term and its consensus definitions were codified by the World Society of the Abdominal Compartment Syndrome (WSACS) only in the early 2000s, the physiological underpinnings have been observed for over 150 years. In 1863, the French physiologist Etienne-Jules Marey was the first to document the reciprocal relationship between intra-abdominal pressure (IAP) and respiratory function, noting that the expansion of the abdominal cavity directly impacted the efficiency of the thoracic bellows.

July 18

Assessment of Postoperative Fever

For the physician and the student of medicine, the assessment of postoperative fever is not merely a task of temperature monitoring, but a diagnostic journey that requires a nuanced understanding of immunology, physiology, and clinical timing. Guided by the principle of "Primum non nocere," this report seeks to bridge the gap between complex pathophysiological mechanisms and the empathetic care of the patient, providing a comprehensive framework for identifying, understanding, and managing this common clinical challenge.

July 14

Clinical Review of Congenital and Acquired Cystic Kidney Diseases

The healing arts, as envisioned by the ancient traditions of medicine, seek not merely the eradication of pathology but the restoration of a delicate equilibrium between the body’s internal environment and the external world. In the realm of nephrology, cystic diseases of the kidney represent a profound disruption of this balance.

Spotlight

A Comprehensive Analysis of Complement System Deficiencies in Pediatric and Adult Populations

The human immune system is a tapestry of ancient evolutionary mechanisms and highly specialized adaptive responses, woven together to maintain the delicate equilibrium of health. At the heart of this architecture lies the complement system, a complex network of over fifty proteins that function as the primordial vanguard of innate immunity. Named for its ability to "complement" the action of antibodies, this system serves as a bridge between the immediate, non-specific recognition of pathogens and the targeted, long-term memory of the adaptive immune response. However, when this sentinel falls silent due to genetic or acquired deficiencies, the result is a state of nuanced immunosuppression that significantly alters the human clinical landscape across all ages.